Will Adicet Bio and Nanthealth (USA Stocks:NH) make up?

NH Stock  USD 3.59  0.13  3.76%   
As many rational traders are trying to avoid health care technology space, it makes sense to concentrate on Nanthealth LLC a little further and understand how it stands against Adicet Bio and other similar entities. We are going to examine some of the competitive aspects of both Nanthealth and Adicet.
Published over a month ago
View all stories for Nanthealth LLC | View All Stories
By analyzing existing technical indicators between Nanthealth LLC and Adicet, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Adicet with a short position in Nanthealth LLC. Check out our pair correlation module for more information.

Let's begin by analyzing the assets.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nanthealth LLC has an asset utilization ratio of 31.67 percent. This implies that the company is making $0.32 for each dollar of assets. An increasing asset utilization means that Nanthealth LLC is more efficient with each dollar of assets it utilizes for everyday operations.

How important is Nanthealth LLC's Liquidity

Nanthealth LLC financial leverage refers to using borrowed capital as a funding source to finance Nanthealth LLC ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Nanthealth LLC financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Nanthealth LLC's total debt and its cash.

How does Nanthealth utilize its cash?

To perform a cash flow analysis of Nanthealth LLC, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Nanthealth LLC is receiving and how much cash it distributes out in a given period. The Nanthealth LLC cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Nanthealth LLC Net Cash Flow from Operations is increasing as compared to previous years. The last year's value of Net Cash Flow from Operations was reported at (26.67 Million)

Nanthealth LLC exotic insider transaction detected

Legal trades by Nanthealth LLC insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Nanthealth insider trading alert for general transaction of common stock by Patrick SoonShiong, Chairman and Chief Executive Officer, on 31st of December 2022. This event was filed by Nanthealth Inc with SEC on 2016-06-01. Initial filing of beneficial ownership - SEC Form 3 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

What is the case for Nanthealth LLC Investors

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Now, let's check Nanthealth LLC revenue. Based on the latest financial disclosure, Nanthealth LLC reported 62.65 M of revenue. This is 99.18% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 99.34% higher than that of Nanthealth LLC. As for Adicet Bio we see revenue of 9.73 M, which is much higher than that of the Health Care

NH
62.6 M
NH62.65 Million86.56
Sector0.00.0
ACET9.73 Million13.44

Nanthealth LLC implied volatility may change after the rise

Current Information Ratio is up to 0.02. Price may drop again. Nanthealth LLC is showing large volatility of returns over the selected time horizon. We encourage all investors to investigate this asset further to ensure that related market timing strategies are aligned with all the expectations about Nanthealth LLC implied risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nanthealth LLC's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nanthealth LLC's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Final Perspective on Nanthealth LLC

While some other companies under the health information services industry are still a bit expensive, Nanthealth LLC may offer a potential longer-term growth to stockholders. With a less-than optimistic outlook for your 90 days horizon, it may be a good time to exit some or all of your Nanthealth LLC holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Nanthealth LLC.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Nanthealth LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com